Marcia B. Podlisny

7.5k total citations · 2 hit papers
38 papers, 6.2k citations indexed

About

Marcia B. Podlisny is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Marcia B. Podlisny has authored 38 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 24 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Marcia B. Podlisny's work include Alzheimer's disease research and treatments (30 papers), Prion Diseases and Protein Misfolding (16 papers) and Computational Drug Discovery Methods (5 papers). Marcia B. Podlisny is often cited by papers focused on Alzheimer's disease research and treatments (30 papers), Prion Diseases and Protein Misfolding (16 papers) and Computational Drug Discovery Methods (5 papers). Marcia B. Podlisny collaborates with scholars based in United States, Canada and Ireland. Marcia B. Podlisny's co-authors include Dennis J. Selkoe, Dominic M. Walsh, David B. Teplow, Gloria Lee, Edward H. Koo, Tilman Oltersdorf, Donald L. Price, Lawrence K. Duffy, Carmela R. Abraham and Christian Haass and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Marcia B. Podlisny

38 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation

1998 671 citations Dominic M. Walsh, Jimin Zhang et al. Journal of Biological Chemistry profile →
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

1988 500 citations Marcia B. Podlisny, Tilman Oltersdorf et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcia B. Podlisny United States	30	5.4k	3.2k	1.3k	1.1k	837	38	6.2k
Dennis J. Selkoe United States	15	4.8k 0.9×	3.2k 1.0×	1.3k 1.0×	1.2k 1.1×	898 1.1×	17	6.4k
Caine W. Wong United States	8	4.8k 0.9×	3.0k 1.0×	1.1k 0.8×	935 0.8×	781 0.9×	9	6.0k
Jan Näslund Sweden	30	5.4k 1.0×	3.4k 1.1×	1.4k 1.1×	1.0k 0.9×	1.0k 1.2×	51	7.0k
Axel Unterbeck United States	12	4.8k 0.9×	3.3k 1.0×	1.0k 0.8×	1.0k 0.9×	767 0.9×	16	5.6k
Carmen Vigo‐Pelfrey United States	18	6.1k 1.1×	3.5k 1.1×	1.5k 1.2×	1.0k 0.9×	1.1k 1.3×	18	7.3k
Steven G. Younkin United States	22	4.2k 0.8×	2.1k 0.7×	997 0.8×	1.0k 0.9×	723 0.9×	30	5.0k
Nikolaos K. Robakis United States	51	4.3k 0.8×	4.1k 1.3×	1.1k 0.9×	1.6k 1.5×	516 0.6×	133	7.3k
Debra Yager United States	16	3.9k 0.7×	2.1k 0.6×	1.2k 0.9×	1.2k 1.1×	725 0.9×	18	4.6k
Lisa McConlogue United States	31	6.0k 1.1×	3.6k 1.1×	1.7k 1.3×	2.2k 2.0×	1.1k 1.3×	41	8.2k
Stephen D. Schmidt United States	30	5.6k 1.0×	2.8k 0.9×	1.3k 1.0×	1.2k 1.1×	802 1.0×	38	7.4k

Countries citing papers authored by Marcia B. Podlisny

Since Specialization

Citations

This map shows the geographic impact of Marcia B. Podlisny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia B. Podlisny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia B. Podlisny more than expected).

Fields of papers citing papers by Marcia B. Podlisny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia B. Podlisny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia B. Podlisny. The network helps show where Marcia B. Podlisny may publish in the future.

Co-authorship network of co-authors of Marcia B. Podlisny

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia B. Podlisny. A scholar is included among the top collaborators of Marcia B. Podlisny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia B. Podlisny. Marcia B. Podlisny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davis, Richard C., Michael T. Maloney, Laurie S. Minamide, et al.. (2011). Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation. Molecular Neurodegeneration. 6(1). 10–10. 74 indexed citations

Klyubin, Igor, Dominic M. Walsh, Geereesh Shankar, et al.. (2005). The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention. Biochemical Society Transactions. 33(5). 1087–1087. 172 indexed citations

Walsh, Dominic M., Matthew Townsend, Marcia B. Podlisny, et al.. (2005). Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation. Journal of Neuroscience. 25(10). 2455–2462. 248 indexed citations

Selkoe, Dennis J. & Marcia B. Podlisny. (2002). Deciphering the Genetic Basis of Alzheimer's Disease. Annual Review of Genomics and Human Genetics. 3(1). 67–99. 228 indexed citations

Podlisny, Marcia B., Martin Citron, Patricia Amarante, et al.. (1997). Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue. Neurobiology of Disease. 3(4). 325–337. 250 indexed citations

Xia, Weiming, Jimin Zhang, Dora Kholodenko, et al.. (1997). Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins. Journal of Biological Chemistry. 272(12). 7977–7982. 243 indexed citations

Cummings, B., Takao Satou, Elizabeth Head, et al.. (1996). Diffuse plaques contain C-terminal Aβ42 and not Aβ40: Evidence from cats and dogs. Neurobiology of Aging. 17(4). 653–659. 109 indexed citations

Selkoe, Dennis J., Tsuneo Yamazaki, Martin Citron, et al.. (1996). The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina. Annals of the New York Academy of Sciences. 777(1). 57–64. 217 indexed citations

Walter, Jochen, Anja Capell, Jürgen Grünberg, et al.. (1996). The Alzheimer’s Disease-Associated Presenilins Are Differentially Phosphorylated Proteins Located Predominantly within the Endoplasmic Reticulum. Molecular Medicine. 2(6). 673–691. 178 indexed citations

10.

Podlisny, Marcia B., Beth L. Ostaszewski, Sharon L. Squazzo, et al.. (1995). Aggregation of Secreted Amyloid β-Protein into Sodium Dodecyl Sulfate-stable Oligomers in Cell Culture. Journal of Biological Chemistry. 270(16). 9564–9570. 311 indexed citations

11.

Bons, N, Nadine Mestre‐Francés, Karen Ritchie, et al.. (1994). Identification of amyloid beta protein in the brain of the small, short-lived Lemurian primate Microcebus murinus. Neurobiology of Aging. 15(2). 215–220. 57 indexed citations

12.

Maness, Lawrence M., William A. Banks, Marcia B. Podlisny, Dennis J. Selkoe, & Abba J. Kastin. (1994). Passage of human amyloid β-protein 1–40 across the murine blood-brain barrier. Life Sciences. 55(21). 1643–1650. 104 indexed citations

13.

Podlisny, Marcia B., Diane Stephenson, Matthew P. Frosch, et al.. (1993). Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity.. PubMed. 142(1). 17–24. 58 indexed citations

14.

Fraser, Paul E., Jack Nguyen, Hideyo Inouye, et al.. (1992). Fibril formation by primate, rodent, and Dutch-hemorrhagic analogs of Alzheimer amyloid .beta.-protein. Biochemistry. 31(44). 10716–10723. 218 indexed citations

15.

Podlisny, Marcia B., Diane Stephenson, Matthew P. Frosch, et al.. (1992). Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiology of Aging. 13(5). 561–567. 52 indexed citations

16.

Bodmer, Stefan, Marcia B. Podlisny, Dennis J. Selkoe, Irma Heid, & A. Fontana. (1990). Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. Biochemical and Biophysical Research Communications. 171(2). 890–897. 49 indexed citations

17.

Podlisny, Marcia B., Andrew L. Mammen, Michael G. Schlossmacher, et al.. (1990). Detection of soluble forms of the β-amyloid precursor protein in human plasma. Biochemical and Biophysical Research Communications. 167(3). 1094–1101. 63 indexed citations

18.

Palmert, Mark R., Marcia B. Podlisny, Tilman Oltersdorf, et al.. (1989). The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.. Proceedings of the National Academy of Sciences. 86(16). 6338–6342. 212 indexed citations

19.

Snow, Alan D., Michael G. Kinsella, David Nochlin, et al.. (1989). A CHARACTERISTIC BINDING AFFINITY BETWEEN HEPARAN SULFATE PROTEOGLYCANS AND THE A4 AMYLOID PROTEIN OF ALZHEIMERʼS DISEASE. Journal of Neuropathology & Experimental Neurology. 48(3). 352–352. 22 indexed citations

20.

Palmert, Mark R., et al.. (1988). Antisera to an amino-terminal peptide detect the amyloid protein precursor of alzheimer's disease and recognize senile plaques. Biochemical and Biophysical Research Communications. 156(1). 432–437. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact